ArticleACS omega2021
Ranking-Oriented Quantitative Structure-Activity Relationship Modeling Combined with Assay-Wise Data Integration.
Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Data-Driven Evaluation for Multicriteria Selection of Covalent Organic Frameworks for Membrane-Based Hydrogen Separation.ACS omega · 2026Article
- Computational Study of Enzyme Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026Article
- Design, synthesis, anticancer properties, and molecular docking of imidazolone derivatives with lipophilic moiety.Scientific reports · 2025Article
- Leveraging bounded datapoints to classify molecular potency improvements.RSC medicinal chemistry · 2024Article
- Finding the most potent compounds using active learning on molecular pairs.Beilstein journal of organic chemistry · 2024Article
- Application of Machine Learning in Developing Quantitative Structure-Property Relationship for Electronic Properties of Polyaromatic Compounds.ACS omega · 2022Article
- Ligand-based approaches to activity prediction for the early stage of structure-activity-relationship progression.Journal of computer-aided molecular design · 2022Article
- Integrating Incompatible Assay Data Sets with Deep Preference Learning.ACS medicinal chemistry letters · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In ligand-based drug design, quantitative structure-activity relationship (QSAR) models play an important role in activity prediction. One of the major end points of QSAR models is half-maximal inhibitory concentration (IC
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.